RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1136%2Fbmj-2024-083382
https://w3id.org/ripe/ripe-kg/work/10.1136%2Fbmj-2024-083382
| Subject | Predicate | Object |
|---|---|---|
ripekg:publication-details/RIPEA148131811A593CEDPrevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:publication-details/RIPEA148131811A593CEDPrevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:publication-details/RIPEA44677276976C010DPrevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:publication-details/RIPEA44677276976C010DPrevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:registry-evidence/RIPEA148131811A593CED |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:registry-evidence/RIPEA44677276976C010D |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:registry-evidence/RIPEA44677276976C010D |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:research-integrity-assessment/RIPEA148131811A593CED |
ripe:assesses |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:research-integrity-assessment/RIPEA148131811A593CED |
ripe:assesses |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:research-integrity-assessment/RIPEA44677276976C010D |
ripe:assesses |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:research-integrity-assessment/RIPEA44677276976C010D |
ripe:assesses |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:study-design-evidence/RIPEA148131811A593CED |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:study-design-evidence/RIPEA148131811A593CED |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:study-design-evidence/RIPEA44677276976C010D |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:study-design-evidence/RIPEA44677276976C010D |
ripe:concerns |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
prism:doi |
10.1136/bmj-2024-083382 |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
prism:doi |
10.1136/bmj-2024-083382 |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAU3CBA80E09D568187Ahmad Monabati |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAU3CBA80E09D568187Ahmad Monabati |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAU4DA266C4CEC5137DAnthony Mathur |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAU4DA266C4CEC5137DAnthony Mathur |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAU4F3A08DE0BAE211AMohammad Kasaei |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAU4F3A08DE0BAE211AMohammad Kasaei |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAU8C3DA0BA4E012CE7Massoud Vosough |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAU8C3DA0BA4E012CE7Massoud Vosough |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAUA477C80858509C5BYahya Kiwan |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAUA477C80858509C5BYahya Kiwan |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAUBBDC03C087EADF01Firoozeh Abtahi |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAUBBDC03C087EADF01Firoozeh Abtahi |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAUC14461A5547C6EE4Armin Attar |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAUC14461A5547C6EE4Armin Attar |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAUD06A77ECB195F21FSeyed Mirhosseini |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAUD06A77ECB195F21FSeyed Mirhosseini |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAUD54BE25D3FFA51A0Negar Azarpira |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAUD54BE25D3FFA51A0Negar Azarpira |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:creator |
ripekg:author/RIPEAUDFE689BBE3E051B4Sheik Dowlut |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:creator |
ripekg:author/RIPEAUDFE689BBE3E051B4Sheik Dowlut |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:title |
Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:title |
Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
dcterms:title |
e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
dcterms:title |
e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1001%2Farchinte.163.19.2345Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1001%2Farchinte.163.19.2345Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1001%2Fjama.2013.282909Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1001%2Fjama.2013.282909Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1002%2Fehf2.13144Heart failure after myocardial infarction: incidence and predictors |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1002%2Fehf2.13144Heart failure after myocardial infarction: incidence and predictors |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1002%2Fsctm.16-0484Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1002%2Fsctm.16-0484Concise Review: Mesenchymal Stem Cells in Cardiovascular Regeneration: Emerging Research Directions and Clinical Applications |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1007%2Fs11136-016-1366-7Sustained quality of life improvement after intracoronary injection of autologous bone marrow cells in the setting of acute myocardial infarction: results from the BONAMI trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1007%2Fs11136-016-1366-7Sustained quality of life improvement after intracoronary injection of autologous bone marrow cells in the setting of acute myocardial infarction: results from the BONAMI trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.ahj.2011.06.019Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jacadv.2023.100294Sex Differences in Heart Failure Following Acute Coronary Syndromes |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jacadv.2023.100294Sex Differences in Heart Failure Following Acute Coronary Syndromes |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jacc.2022.11.061Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jacc.2022.11.061Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jchf.2017.09.015Post-myocardial infarction heart failure |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jchf.2017.09.015Post-myocardial infarction heart failure |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jcyt.2024.10.008Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fj.jcyt.2024.10.008Delphi-driven consensus definition for mesenchymal stromal cells and clinical reporting guidelines for mesenchymal stromal cell-based therapeutics |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fs0140-6736%2804%2916626-9Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fs0140-6736%2804%2916626-9Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fs0735-1097%2825%2902274-0Sex difference in the development and progression of heart failure after firsttime ST-elevation myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1016%2Fs0735-1097%2825%2902274-0Sex difference in the development and progression of heart failure after firsttime ST-elevation myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1038%2Fs41419-020-2542-9The therapeutic potential of mesenchymal stem cells for cardiovascular diseases |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1038%2Fs41419-020-2542-9The therapeutic potential of mesenchymal stem cells for cardiovascular diseases |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1056%2Fnejmoa055706Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1056%2Fnejmoa055706Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1056%2Fnejmoa060186REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1056%2Fnejmoa060186REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1080%2F14653240600855905Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1080%2F14653240600855905Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1080%2F14712598.2023.2245329Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1080%2F14712598.2023.2245329Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1089%2Fars.2009.2455Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1089%2Fars.2009.2455Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehaa651The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehaa651The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehl388REPAIR-AMI Investigators. Improved clinical outcome after intracoronary administration of bonemarrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehl388REPAIR-AMI Investigators. Improved clinical outcome after intracoronary administration of bonemarrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehp073REGENT Investigators. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehp073REGENT Investigators. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehu062REPAIR-AMI Study Group. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines eventfree survival |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehu062REPAIR-AMI Study Group. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines eventfree survival |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehx188Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1093%2Feurheartj%2Fehx188Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1136%2Fheartjnl-2014-305892HEBE investigators. Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1136%2Fheartjnl-2014-305892HEBE investigators. Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1161%2Fcircresaha.116.308639Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1161%2Fcircresaha.116.308639Effect of Bone Marrow-Derived Mononuclear Cell Treatment, Early or Late After Acute Myocardial Infarction: Twelve Months CMR and Long-Term Clinical Results |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1161%2Fcirculationaha.108.784215Long-term trends in the incidence of heart failure after myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1161%2Fcirculationaha.108.784215Long-term trends in the incidence of heart failure after myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1161%2Fjaha.122.028942Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MI |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1161%2Fjaha.122.028942Sex Differences in Clinical Characteristics and Outcomes After Myocardial Infarction With Low Ejection Fraction: Insights From PARADISE-MI |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs12872-022-02701-xMajor cardiovascular events after bone marrow mononuclear cell transplantation following acute myocardial infarction: an updated post-BAMI meta-analysis of randomized controlled trials |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs12872-022-02701-xMajor cardiovascular events after bone marrow mononuclear cell transplantation following acute myocardial infarction: an updated post-BAMI meta-analysis of randomized controlled trials |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs12872-022-02701-x18Major cardiovascular events after bone marrow mononuclear cell transplantation following acute myocardial infarction: an updated post-BAMI meta-analysis of randomized controlled trials |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs12872-022-02701-x18Major cardiovascular events after bone marrow mononuclear cell transplantation following acute myocardial infarction: an updated post-BAMI meta-analysis of randomized controlled trials |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs12916-015-0399-zIntracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs12916-015-0399-zIntracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs13287-021-02513-4Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized doubleblind sham-controlled clinical trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs13287-021-02513-4Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized doubleblind sham-controlled clinical trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs13287-021-02609-xThe safety of MSC therapy over the past 15 years: a meta-analysis |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs13287-021-02609-xThe safety of MSC therapy over the past 15 years: a meta-analysis |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs13287-021-02667-1Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs13287-021-02667-1Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs13287-023-03495-1Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.1186%2Fs13287-023-03495-1Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.3389%2Ffcell.2020.00458Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.3389%2Ffcell.2020.00458Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.3389%2Ffcvm.2017.00047Cardiac Stem Cells for Myocardial Regeneration: They Are Not Alone |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.3389%2Ffcvm.2017.00047Cardiac Stem Cells for Myocardial Regeneration: They Are Not Alone |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.3389%2Ffcvm.2022.961920First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.3389%2Ffcvm.2022.961920First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarction |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/10.3389%2Ffcvm.2022.96192035Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/10.3389%2Ffcvm.2022.96192035Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW65EF36A3F9EA2882Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW65EF36A3F9EA2882Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
rdf:type |
node1 |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
rdf:type |
node1 |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
rdf:type |
rdfs:Resource |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
rdf:type |
rdfs:Resource |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
rdf:type |
owl:Thing |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
rdf:type |
owl:Thing |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
rdf:type |
prov:Entity |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
rdf:type |
prov:Entity |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8) |
owl:sameAs |
https://semopenalex.org/work/W4415679667 |
ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies |
owl:sameAs |
https://semopenalex.org/work/W4415679667 |